CurcuminCurcumin
herb
别名: Turmeric Extract, Curcuma longa, Diferuloylmethane, Theracurmin, Longvida, Meriva
About
Curcumin, the active compound in turmeric, is a potent modulator of vascular inflammation through NF-kB, JAK/STAT, and MAPK pathway inhibition. A 2017 meta-analysis found curcumin significantly reduced total cholesterol, LDL, and triglycerides in metabolic syndrome patients. Enhanced bioavailability formulations (Theracurmin, Longvida, Meriva) provide 25-185x improvements over standard curcumin.
How It Works
Potent modulator of vascular inflammation through NF-kB, JAK/STAT, and MAPK pathway inhibition; reduces endothelial expression of adhesion molecules decreasing monocyte recruitment; improves endothelial function by enhancing eNOS expression and nitric oxide bioavailability; reduces ox-LDL uptake by macrophages inhibiting foam cell formation; anti-thrombotic activity via COX-2 inhibition.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| Cardiovascular Inflammation | B | 12 | 1000 | 查看 → |
| High Cholesterol (Hyperlipidemia) | C | 7 | 500 | 查看 → |
Side Effects
- Gastrointestinal discomfort (nausea, diarrhea)
- Yellow staining of skin/teeth at high doses
- May increase gallbladder contractions
- Headache (rare)
Drug & Supplement Interactions
- Anticoagulants (may increase bleeding risk)
- Antiplatelet drugs (additive antiplatelet effect)
- Diabetes medications (may lower blood sugar)
- CYP3A4 substrates (may alter metabolism)
- Iron supplements (curcumin may chelate iron)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。